Life-Saving Device Could Transform The Medical Market in 2017
by noreply@blogger.com (brian wang) from NextBigFuture.com on (#29BC2)
A little-known biotech company is poised to potentially earn millions in revenue with the planned upcoming release of a breakthrough technology that could prevent massive numbers of strokes with a simple test that is affordable and accessible to the average American.
A Multi-Billion- Dollar Problem with a $49,000 Answer
Stroke statistics are shocking: Globally, every year 15 million people suffer a stroke. Of these, some 6 million are killed, while 5 million are rendered permanently disabled. In the U.S. alone, nearly 800,000 people suffer from strokes annually-and someone dies of a stroke every 4 minutes.
Until now, there has been no cost-effective way to screen for Ischemia, the leading indicator of a stroke, which cost the U.S. government alone tens of billions of dollars a year. That could be about to change, thanks to a breakthrough technology from CVR Medical (TSX:CVM.V ; OTC:CRRVF. The company's debut, game-changing medical device has been quietly in development for 10 years, and now it's about to charge out of the gate, hoping to take the market by storm upon FDA market clearance.
What 3D seismic imagery did for super quick discoveries in the oil and gas industry, CVR's sensory system could do for the medical industry.
CVR's Carotid Stenotic Scan (CSS) is a tool to detect stenosis within the Carotid Arteries, potentially offering patients and caregivers a device for early detection in a quick and repeatable manner. Unlike other comparative modalities, the CSS was designed to function without the assistance of a certified technician. These three facts combine to create one of the potentially biggest-and most lucrative-- phenomena in recent medical equipment market history.
Read more
A Multi-Billion- Dollar Problem with a $49,000 Answer
Stroke statistics are shocking: Globally, every year 15 million people suffer a stroke. Of these, some 6 million are killed, while 5 million are rendered permanently disabled. In the U.S. alone, nearly 800,000 people suffer from strokes annually-and someone dies of a stroke every 4 minutes.
Until now, there has been no cost-effective way to screen for Ischemia, the leading indicator of a stroke, which cost the U.S. government alone tens of billions of dollars a year. That could be about to change, thanks to a breakthrough technology from CVR Medical (TSX:CVM.V ; OTC:CRRVF. The company's debut, game-changing medical device has been quietly in development for 10 years, and now it's about to charge out of the gate, hoping to take the market by storm upon FDA market clearance.
What 3D seismic imagery did for super quick discoveries in the oil and gas industry, CVR's sensory system could do for the medical industry.
CVR's Carotid Stenotic Scan (CSS) is a tool to detect stenosis within the Carotid Arteries, potentially offering patients and caregivers a device for early detection in a quick and repeatable manner. Unlike other comparative modalities, the CSS was designed to function without the assistance of a certified technician. These three facts combine to create one of the potentially biggest-and most lucrative-- phenomena in recent medical equipment market history.
Read more